Purpose The objectives of this review are to summarize the role of gastric motor functions in
the development of satiation (defined broadly as postprandial fullness) and satiety (reduced …

Obesity treatment requires a chronic state of negative energy balance. Obesity medications
can help with this, increasing long‐term dietary compliance by promoting satiety or reducing …

Background Obesity has reached epidemic proportions, with> 40% of the US population
affected. Although traditionally managed by lifestyle modification, and less frequently by …

The objective is to review the newer pharmacological interventions for obesity, specifically
single, dual and triple incretin receptor agonists that are either available or in the pipeline for …

The aims of this review are to appraise the role of the stomach in satiation, the effects of
incretin and other hormone agonists on weight loss and the role of altered gastric functions …

Abstract Glucagon-like peptide-1 (GLP-1) is a 30-amino acid peptide hormone that is mainly
expressed in the intestine and hypothalamus. In recent years, basic and clinical studies …

Aim: To analyze roles of single nucleotide variants (SNVs) on weight loss with US FDA-
approved medications. Materials & methods: We searched the literature up until November …